Nomura Holdings, Inc. · NMR · FY2026 Q4 · Calendar Q2 2026
Nomura posts strong full-year growth as Q4 profit faces impairments
The supplied analysis supports a constructive but qualified view: recurring-revenue growth, rising assets under management, private-credit expansion and a 10.1% ROE support Nomura's medium-term trajectory, while Q4 impairments, affiliate weakness, cost pressures and market exposure remain material counterweights.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about NMR FY2026 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The latest analysis adds a strong full-year result and record net income, but highlights a weaker Q4 driven by lower affiliate profit and a forestry asset-management impairment. It also emphasizes expanded private-credit activity, record Wealth Management recurring revenue and continued AI and digital investment.
Guidance delta
No formal guidance sentiment was provided in the supplied analysis.
Key takeaways
- Full-year revenue rose 15% year over year and ROE reached 10.1%, meeting the 2030 target.
- Wealth Management recurring revenue and Investment Management AUM expanded, supporting the growth case.
- Q4 pre-tax income fell 20% as affiliate profit declined and impairment losses weighed on results.
Management priorities
- Monetize recent acquisitions and expand private credit.
- Grow recurring-revenue assets and active ETFs.
- Pursue cost control while investing in AI and digital wealth-management capabilities.
Follow NMR with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 1, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Neutral | Upgrade | Mar 19, 2026 |
| Jefferies | Hold | Buy | Downgrade | Jan 25, 2023 |
| Goldman Sachs | Neutral | Buy | Downgrade | Mar 30, 2021 |
| Credit Suisse | Neutral | Outperform | Downgrade | Feb 10, 2016 |
| Deutsche Bank | Hold | Buy | Downgrade | Feb 8, 2016 |
| UBS | Neutral | Buy | Downgrade | Jul 22, 2015 |
| Barclays | Equal Weight | Underperform | Upgrade | Jun 23, 2015 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Mar 21, 2013 |
| Macquarie | Outperform | Neutral | Upgrade | Feb 14, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $9.38. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Nomura | Natsumu Tsujino | $10.2 | $8.61 | +8.7% | Jun 25, 2026 |
| Bank of America Securities | Natsumu Tsujino | $5.79 | $5.22 | -38.3% | Oct 22, 2024 |
Track every rating change on NMR the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationNomura Holdings, Inc. engages in the provision of investment, financing, and related services to individual, institutional, and government clients worldwide. It operates through three segments: Wealth Management, Investment Management, and Wholesale. The Wealth Management segment offers investment consultation services. The Investment Management segment provides investment management services and investment solutions, such as establishing and managing investment trusts, discretionary investment services, as well as investment and management for investment vehicles, and for funds for…
Historical context
All NMR earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CBOE Cboe Global Markets, Inc. | FY2026 Q3 · Calendar Q4 2026 | +5.8% | +6.8% | Cboe posts strong Q3 as options growth and new products advance |
| NWG NatWest Group plc | FY2026 Q3 · Calendar Q4 2026 | +2.0% | -9.0% | NatWest maintains guidance as Q3 growth and capital remain strong |
| ERIE Erie Indemnity Company | FY2026 Q3 · Calendar Q4 2026 | +2.1% | +5.3% | Erie pairs resilient demand initiatives with thin underwriting margins |
| COIN Coinbase Global, Inc. | FY2026 Q3 · Calendar Q4 2026 | +1189.2% | -10.6% | Coinbase offsets lower spot trading with prediction markets and AI agents |
| TPG TPG Inc. | FY2026 Q3 · Calendar Q4 2026 | +4.3% | +7.5% | TPG raises FRE margin outlook as capital formation accelerates |
| AJG Arthur J. Gallagher & Co. | FY2026 Q3 · Calendar Q4 2026 | +0.3% | +2.9% | AJG: Q3 growth and AssuredPartners synergies support outlook |
Latest beats and misses
Who reports nextBeat on EPS
- CHDFY2026 Q3 · October 30, 2026+2.2% EPS+1.2% move
- AZNFY2026 Q3 · October 30, 2026+7.3% EPS+7.0% move
- FRTFY2026 Q3 · October 30, 2026+3.9% EPS-1.1% move
- CVXFY2026 Q3 · October 30, 2026+8.4% EPS+1.8% move
- BTSGFY2026 Q3 · October 30, 2026+14.2% EPS+11.1% move
- EXCFY2026 Q3 · October 30, 2026+10.4% EPS+0.5% move
Missed on EPS
- GLPIFY2026 Q3 · October 29, 2026-11.5% EPS-1.3% move
- LYBFY2026 Q3 · October 30, 2026-1.2% EPS+5.0% move
- CCJFY2026 Q3 · October 30, 2026-101.4% EPS-7.9% move
- VALEFY2026 Q3 · October 29, 2026-24.6% EPS+1.9% move
- DLR-PLFY2026 Q3 · October 29, 2026-8.4% EPS— move
- DLR-PKFY2026 Q3 · October 29, 2026-8.4% EPS— move
Get the NMR recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-11-01T03:50:40.305421+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-01T03:50:40.302734+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-01. For educational purposes only; not investment advice.